PRO-DEX, INC. Revenue Breakdown
No Revenue Breakdown for PDEX on this site yet.
- 2026-06-30: Others Not split by product in the filing$77.55M100.00%; Total revenue $77.55M.
- 2025-06-30: Others Not split by product in the filing$66.59M100.00%; Total revenue $66.59M.
- 2024-06-30: Others Not split by product in the filing$53.84M100.00%; Total revenue $53.84M.
- 2023-06-30: Others Not split by product in the filing$46.09M100.00%; Total revenue $46.09M.
Source checked: the stored Revenue Breakdown page for PDEX.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product in the filing $77.55M 100.00% | $77.55M |
| 2025-06-30 | Not split by product in the filing $66.59M 100.00% | $66.59M |
| 2024-06-30 | Not split by product in the filing $53.84M 100.00% | $53.84M |
| 2023-06-30 | Not split by product in the filing $46.09M 100.00% | $46.09M |
| 2022-06-30 | Not split by product in the filing $42.04M 100.00% | $42.04M |
| 2021-06-30 | Not split by product in the filing $38.03M 100.00% | $38.03M |
| 2020-06-30 | Not split by product in the filing $34.83M 100.00% | $34.83M |
| 2019-06-30 | Not split by product in the filing $27.17M 100.00% | $27.17M |
| 2018-06-30 | Not split by product in the filing $22.46M 100.00% | $22.46M |
| 2017-06-30 | Not split by product in the filing $21.94M 100.00% | $21.94M |
| 2016-06-30 | Not split by product in the filing $20.16M 100.00% | $20.16M |
| 2015-06-30 | Not split by product in the filing $13.38M 100.00% | $13.38M |
| 2014-06-30 | Not split by product in the filing $10.81M 100.00% | $10.81M |
| 2013-06-30 | Not split by product in the filing $722.00K 100.00% | $722.00K |
| 2012-06-30 | Not split by product in the filing $6.71M 100.00% | $6.71M |
| 2011-06-30 | Not split by product in the filing $24.06M 100.00% | $24.06M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $20.41M 100.00% | $20.41M |
| 2026-03-31 | Not split by product $19.95M 100.00% | $19.95M |
| 2025-12-31 | Not split by product $18.66M 100.00% | $18.66M |
| 2025-09-30 | Not split by product $18.53M 100.00% | $18.53M |
| 2025-06-30 | Not split by product $17.49M 100.00% | $17.49M |
| 2025-03-31 | Not split by product $17.41M 100.00% | $17.41M |
| 2024-12-31 | Not split by product $16.79M 100.00% | $16.79M |
| 2024-09-30 | Not split by product $14.89M 100.00% | $14.89M |
| 2024-06-30 | Not split by product $15.03M 100.00% | $15.03M |
| 2024-03-31 | Not split by product $14.29M 100.00% | $14.29M |
| 2023-12-31 | Not split by product $12.59M 100.00% | $12.59M |
| 2023-09-30 | Not split by product $11.94M 100.00% | $11.94M |
| 2023-06-30 | Not split by product $10.64M 100.00% | $10.64M |
| 2023-03-31 | Not split by product $13.08M 100.00% | $13.08M |
| 2022-12-31 | Not split by product $11.28M 100.00% | $11.28M |
| 2022-09-30 | Not split by product $11.09M 100.00% | $11.09M |
| 2022-06-30 | Not split by product $12.62M 100.00% | $12.62M |
| 2022-03-31 | Not split by product $9.27M 100.00% | $9.27M |
| 2021-12-31 | Not split by product $10.17M 100.00% | $10.17M |
| 2021-09-30 | Not split by product $9.99M 100.00% | $9.99M |
| 2021-06-30 | Not split by product $9.44M 100.00% | $9.44M |
| 2021-03-31 | Not split by product $11.74M 100.00% | $11.74M |
| 2020-12-31 | Not split by product $8.27M 100.00% | $8.27M |
| 2020-09-30 | Not split by product $8.59M 100.00% | $8.59M |
| 2020-06-30 | Not split by product $11.12M 100.00% | $11.12M |
| 2020-03-31 | Not split by product $8.51M 100.00% | $8.51M |
| 2019-12-31 | Not split by product $7.96M 100.00% | $7.96M |
| 2019-09-30 | Not split by product $7.24M 100.00% | $7.24M |
| 2019-06-30 | Not split by product $7.00M 100.00% | $7.00M |
| 2019-03-31 | Not split by product $6.85M 100.00% | $6.85M |
| 2018-12-31 | Not split by product $6.40M 100.00% | $6.40M |
| 2018-09-30 | Not split by product $6.92M 100.00% | $6.92M |
| 2018-06-30 | Not split by product $6.25M 100.00% | $6.25M |
| 2018-03-31 | Not split by product $5.49M 100.00% | $5.49M |
| 2017-12-31 | Not split by product $5.56M 100.00% | $5.56M |
| 2017-09-30 | Not split by product $5.16M 100.00% | $5.16M |
| 2017-06-30 | Not split by product $5.60M 100.00% | $5.60M |
| 2017-03-31 | Not split by product $6.62M 100.00% | $6.62M |
| 2016-12-31 | Not split by product $4.60M 100.00% | $4.60M |
| 2016-09-30 | Not split by product $5.13M 100.00% | $5.13M |
| 2016-06-30 | Not split by product $4.99M 100.00% | $4.99M |
| 2016-03-31 | Not split by product $5.18M 100.00% | $5.18M |
| 2015-12-31 | Not split by product $5.23M 100.00% | $5.23M |
| 2015-09-30 | Not split by product $4.10M 100.00% | $4.10M |
| 2015-06-30 | Not split by product $4.07M 100.00% | $4.07M |
| 2015-03-31 | Not split by product $3.92M 100.00% | $3.92M |
| 2014-12-31 | Not split by product $2.79M 100.00% | $2.79M |
| 2014-09-30 | Not split by product $2.60M 100.00% | $2.60M |
| 2014-06-30 | Not split by product $3.21M 100.00% | $3.21M |
| 2014-03-31 | Not split by product $2.40M 100.00% | $2.40M |
| 2013-12-31 | Not split by product $2.64M 100.00% | $2.64M |
| 2013-09-30 | Not split by product $2.56M 100.00% | $2.56M |
| 2013-06-30 | Not split by product $2.72M 100.00% | $2.72M |
| 2013-03-31 | Not split by product $3.06M 100.00% | $3.06M |
| 2012-12-31 | Not split by product $3.01M 100.00% | $3.01M |
| 2012-09-30 | Not split by product $3.46M 100.00% | $3.46M |
| 2012-06-30 | Not split by product $3.66M 100.00% | $3.66M |
| 2012-03-31 | Not split by product $4.54M 100.00% | $4.54M |
| 2011-12-31 | Not split by product $4.02M 100.00% | $4.02M |
| 2011-09-30 | Not split by product $5.04M 100.00% | $5.04M |
| 2011-06-30 | Not split by product $6.75M 100.00% | $6.75M |
| 2011-03-31 | Not split by product $6.88M 100.00% | $6.88M |
| 2010-12-31 | Not split by product $6.16M 100.00% | $6.16M |
| 2010-09-30 | Not split by product $5.83M 100.00% | $5.83M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |